International
|
Germany
Investor Relations
|
News
DEUTSCH
SUCHE
Company
Strategy
Internationalisation
High-Quality Supplier
R & D
Cooperations
Values
Management
Supervisory Board
Worldwide
Career
Our offers
Your contacts
History
Contact
Investor Relations
Biotest Share
Facts
Stock History
Shareholder Structure
Charts
Stock Trend
Financial Key Figures
Facts
Fact Sheet
News
Financial Calendar
Publications
Annual Reports
Quarterly Reports
Presentations
Directors´ Dealings
Shareholders´ Meeting 2009
Archive 2008
Archive 2007
Archive 2006
Archive 2005
Archive 2004
Corporate Governance
Declaration of Compliance
Former Declaration of Compliance
Articles of Association
Survey 2005
Annual Dokument 2009
Archive 2008
Archive 2007
Archive 2006
Contact
IR Contact
Info Service
Pharmaceuticals
Plasma proteins
Immunoglobulins
Intratect
Intraglobin F
Pentaglobin
Cytotect CP / Megalotect
Hepatect CP
Zutectra
Varitect CP
Coagulation Factors
Haemoctin SDH
Haemonine
Protein Solutions
Biseko
Human Albumin
Sales Pharmaceuticals International
Germany
Worldwide
Patient Information
Immunoglobulins
Haemophilia
Biotherapeutics
Product pipeline
BT - 061
Rheumatoide Arthritis
Psoriasis
BT - 062
Multiple myeloma
BT - 063
Systemischer Lupus erythematodes (SLE)
Diagnostics
Medical Diagnostics
Microbiological Tests & Systems
News
Hygiene Monitoring
Air Sampler
Agar Media
Particle Counting
Portable Particle Counters
Handheld Part. Counters
Molecular Microbiology
Biotest MMB Food
Hygiene Screening System
Sales & Support
Germany
Worldwide
Download Service
Workshops
heipha Dr. Müller GmbH
Biotest worldwide
Albania
Argentina
Australia
Austria
Bahrain
Bangladesh
Benelux
Bosnia and Herzegovina
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
France
Germany
Great Britain
Greece
Hong Kong
Hungary
India
Indonesia
Irak
Iran
Ireland
Italy
Japan
Jordan
Korea
Kuwait
Latvia
Lebanon
Libya
Lithuania
Macedonia
Malaysia
Malta
Mexico
Montenegro
Oman
Pakistan
Palestine
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sweden
Switzerland
Syria
Taiwan
Thailand
Tunisia
Turkey
United Arab Emirates
USA
Vietnam
Yemen
Ad-hoc News
07/18/2008
DGAP-Ad-hoc: Biotest AG: strong first half year, profit target raised
05/27/2008
DGAP-Ad-hoc: Biotest AG: Forecast for turnover and profit raised
02/22/2008
DGAP-Ad-hoc: Biotest AG: Biotest marked increase in sales and earnings recorded in 2007
09/21/2007
DGAP-Ad-hoc: Biotest AG:Biotest successfully concludes 10% capital increase
09/11/2007
DGAP-Ad-hoc: Biotest AG:Biotest AG acquires plasma protein unit from Nabi Biopharmaceuticals Corp.
07/19/2007
DGAP-Ad-hoc: Biotest AG: Biotest significantly increases sales and earnings target for 2007
02/14/2007
DGAP-Ad-hoc: Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected
05/03/2006
DGAP-Ad-hoc: Biotest AG:Biotest and Sanquin plan a strategic alliance in plasma products
10/10/2005
Ad hoc news: Biotest fixes subscription price
09/06/2005
Ad hoc news: Biotest AG increases capital stock by up to EUR 3.9 million
06/30/2005
Ad hoc news: Biotest AG increases capital stock by 2.92 million Euro
03/24/2005
Ad hoc news: Change of the Supervisory Board
03/16/2005
Ad hoc news: Excellent preliminary result: Biotest achieves group profit of EUR 5.0 million in 2004
04/25/2003
Ad hoc news: Biotest: Positive operating profit before special items from core activities
03/11/2003
Ad hoc news: Notice according to §15 WPHG (German Security Trading Act) Biotest AG's year-end result for 2002 depressed by restructuring expenditure despite sales increase
Corporate News
08/18/2008
DGAP-News: Biotest AG: Biotest: US approval increases potential of diagnostic business
08/07/2008
DGAP-News: Biotest AG: Biotest strengthens self-sufficiency in Plasma Proteins
07/29/2008
DGAP-News: Biotest AG: Biotest awarded patent protection in the USA
05/27/2008
DGAP-News: Biotest AG: Payout of dividends increased, forecast improved
05/16/2008
DGAP-News: Biotest AG: Successful start into the Year 2008
05/05/2008
DGAP-News: Biotest AG: research into additional indications for monoclonal antibody BT-061
04/14/2008
DGAP-News: Biotest AG: European approvals expand the market potential for plasma proteins
04/07/2008
DGAP-News: Biotest AG: Biotest: Successful launch of plasma protein business in the USA
03/11/2008
DGAP-News: Biotest AG: Biotest achieves major milestones in the development of biotherapeutics
02/22/2008
DGAP-News: Biotest AG: 2007 a very successful year for Biotest
12/05/2007
DGAP-News: Biotest AG:Biotest successfully completes acquisition of Nabi Biologics assets
11/09/2007
DGAP-News: Biotest AG: Nabi shareholders approve sale of Biologics Business Unit to Biotest
11/05/2007
DGAP-News: Biotest AG: Biotest: plasmapheresis centre in Dortmund opens
09/11/2007
DGAP-News: Biotest AG:Biotest AG acquires plasma protein business unit from Nabi Biopharmaceuticals Corp.
08/10/2007
DGAP-News: Biotest AG: Biotest remains on course for growth
08/01/2007
DGAP-News: Biotest AG:Biotest and Abbott cooperate on a clinical trial for the expansion of the indication of Cytotect®
07/16/2007
DGAP-News: Biotest AG: New clinical results increase market potential of Cytotect®
06/25/2007
DGAP-News: Biotest AG: Biotest achieves further milestones in its monoclonal antibody development
06/15/2007
DGAP-News: Biotest receives go-ahead to export culture media to the USA
05/03/2007
DGAP-News: Biotest AG: successful start to 2007
03/13/2007
DGAP-News: Biotest AG: Board of Management and Supervisory Board propose 82% dividend increase
02/14/2007
DGAP-News: Biotest AG: 2006 financial year considerably better than expected
01/04/2007
DGAP-News: Biotest AG: Orphan drug status for Cytotect® in the USA
12/21/2006
DGAP-News: Biotest AG: Major milestones achieved in the development of monoclonal antibodies. - Commencement of clinical development of BT-061.
11/14/2006
DGAP-News: Biotest AG: Biotest confirms sales and earnings target following good third quarter
11/02/2006
DGAP-News: Biotest AG:Biotest obtained approval for improved Hepatect® product in six European countries
10/20/2006
DGAP-News: Biotest AG: New Automated Assays for TANGO® Automated Blood Bank Systems under Food and Drug Administration Review
10/20/2006
DGAP-News: Biotest AG: Biotest Diagnostics Corporation Announces Appointment of Vice President, Transfusion Diagnostics
10/20/2006
DGAP-News: Biotest AG: Biotest announces important Milestone for Full Line of Manual Blood Bank Reagents
10/20/2006
DGAP-News: Biotest AG: Olympus and Biotest redefine distribution relationship for Tango® systems
09/28/2006
DGAP-News: Biotest AG: EMEA Committee in favour of Orphan Drug status for Cytotect®
08/14/2006
DGAP-News: Biotest AG: Continuing growth
07/11/2006
DGAP-News: Biotest secures exclusive rights to ImmunoGen’s world leading cytotoxic agent technologyest AG:
05/11/2006
DGAP-News: Biotest AG: Stock option programme fails to achieve required majority
05/11/2006
DGAP-News: Biotest AG:Good start to 2006 - a year of growth: Group sales up by 21%, overproportional growth recorded in earnings
03/22/2006
DGAP-News: Biotest AG:”Focused research, global growth”: Biotest increases its market share worldwide and announces ambitious targets for 2006
03/22/2006
DGAP-News: Biotest AG:Supervisory Board announces early extension of Dr. Michael Ramroth’s (CFO), contract by five years
02/17/2006
DGAP-News: Biotest AG: Successful financial year 2005: Biotest increases sales, doubles the result and reduces financial liabilities
11/14/2005
Press release: Biotest continues excellent business growth in third quarter: Revenue +9%, EBIT +43%
10/31/2005
Press release: Successful capital increase for Biotest
10/18/2005
Press release: Biotest: World’s Largest Trade Conference is Kickoff for TANGO Marketing in the U.S.
10/13/2005
Press release: Biotest: Intratect
®
approved for nine European countries
10/11/2005
Press release: Biotest AG: Capital increase - Up to EUR 30 million for research and internationalisation
09/29/2005
Press release: Biotest: New study doubles the market potential of Cytotect
®
08/05/2005
Press release: Biotest enjoys continued successful business growth - EBIT +27% in first six months 2005
07/28/2005
Press release: Biotest receives approval for TANGO reagents in US
07/01/2005
Press release: Capital increase: 10 million euro in new funds for antibody research
06/29/2005
Press release: Biotest wins TANGO tender
06/28/2005
Press release: Biotest AG and Boehringer Ingelheim Enter Into
05/20/2005
Press release: Biotest AG: Dr. Thorlef Spickschen new Chairman of the Supervisory Board
05/10/2005
Press release: Biotest : Q1 2005 continues positive trend
04/19/2005
Press release: Biotest : Successful fiscal year 2004 and first quarter of 2005
02/17/2005
Press release: Biotest AG and Lonza Enter into Manufacturing Agreement
01/26/2005
Press release: Biotest recorded revenues of EUR 218 million in 2004
01/21/2005
Press release: Biotest AG and AERES Biomedical Successfully Complete Engineering of the Antibody BT-062
11/22/2004
Press release: Biotest increases operating result by 70%
09/30/2004
Press release: STRATEC and BIOTEST conclude agreement on further development of TANGO
09/29/2004
Press release: Biotest launches new antibody product
07/08/2004
Press release: 2004 General Shareholders' Meeting - Biotest shareholders approve extensive capital measures
04/02/2004
Press release: Biotest generates operating profit in 2003
03/10/2004
Press release: Biotest sells its shareholding in SIFIN
02/23/2004
Press release: Biotest and Iranian Darou Pakhsh form joint venture
02/03/2004
Press release: Management changes at Biotest
01/26/2004
Press release: Biotest generates € 222 million turnover in 2003
10/01/2003
Press release: New chairman for the Biotest supervisory board
07/10/2003
Press release: Prof. Schulz appointed as Biotest`s new Chairman
07/01/2003
Press release: Biotest's new preparation against viral infections approved
06/16/2003
Press release: Successful Treatment of SARS Patients with Biotest Drug
06/10/2003
Press release: Biotest sells its shareholding in Envitec
03/05/2003
Press release: Biotest AG continues to market medical products
02/19/2003
Press release: New French transfusion guidelines will drive growth for Biotest's blood grouping analyser
01/29/2003
Press release: Biotest approved for Prime Standard segment
07/09/2002
Press release: Cooperation of Biotest and Olympus in the US and Canadian Market
05/22/2002
Press release: Biotest considers repurchase of shares
04/15/2002
Press release: Biotest AG achieved a 5.6 % growth in sales in 2001 and maintains dividend continuity
02/19/2002
Press release: Biotest announces stock option program
02/12/2002
Press release: Biotest Executive Dr. Reiner retired
01/21/2002
Press release: Biotest fulfills sales target
Ad-hoc News
02/16/2010
DGAP-Ad-hoc: Biotest AG: Biotest significantly increases sales, EBIT above the high level of last year
10/23/2009
DGAP-Ad-hoc: Biotest AG: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad
08/12/2009
DGAP-Ad-hoc: Biotest AG: Ad-hoc RELEASE; Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG)
05/07/2009
DGAP-Ad-hoc: Biotest AG: Press Release- Biotest AG: 'Biotest sales and EBIT growth in first quarter; extension of credit facility'
02/04/2009
DGAP-Ad-hoc: Biotest AG: Biotest records significant growth in sales and earnings, Majority shareholder terminates discussion about shares' sale
10/28/2008
DGAP-Ad-hoc: Biotest AG: Majority shareholder of Biotest AG in discussions about selling shares
07/18/2008
DGAP-Ad-hoc: Biotest AG: strong first half year, profit target raised
05/27/2008
DGAP-Ad-hoc: Biotest AG: Forecast for turnover and profit raised
02/22/2008
DGAP-Ad-hoc: Biotest AG: Biotest marked increase in sales and earnings recorded in 2007
09/21/2007
DGAP-Ad-hoc: Biotest AG:Biotest successfully concludes 10% capital increase
09/11/2007
DGAP-Ad-hoc: Biotest AG:Biotest AG acquires plasma protein unit from Nabi Biopharmaceuticals Corp.
07/19/2007
DGAP-Ad-hoc: Biotest AG: Biotest significantly increases sales and earnings target for 2007
02/14/2007
DGAP-Ad-hoc: Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected
05/03/2006
DGAP-Ad-hoc: Biotest AG:Biotest and Sanquin plan a strategic alliance in plasma products
10/10/2005
Ad hoc news: Biotest fixes subscription price
09/06/2005
Ad hoc news: Biotest AG increases capital stock by up to EUR 3.9 million
06/30/2005
Ad hoc news: Biotest AG increases capital stock by 2.92 million Euro
03/24/2005
Ad hoc news: Change of the Supervisory Board
03/16/2005
Ad hoc news: Excellent preliminary result: Biotest achieves group profit of EUR 5.0 million in 2004
04/25/2003
Ad hoc news: Biotest: Positive operating profit before special items from core activities
03/11/2003
Ad hoc news: Notice according to §15 WPHG (German Security Trading Act) Biotest AG's year-end result for 2002 depressed by restructuring expenditure despite sales increase
Corporate News
01/06/2010
DGAP-News: Biotest AG: Sale of Medical Diagnostics business to Bio-Rad completed
12/07/2009
DGAP-News: Biotest AG: Immunoconjugate BT-062 shows first data of clinical efficacy
12/03/2009
DGAP-News: Biotest AG: European Commission grants approval of Zutectra(R)
11/05/2009
DGAP-News: Biotest AG: Biotest increases sales and earnings
10/23/2009
DGAP-News: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad Biotest AG:
10/20/2009
DGAP-News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in patients with rheumatoid arthritis
09/30/2009
DGAP-News: Biotest AG: Clinical development of BT-063 started
09/28/2009
DGAP-News: Biotest AG: Biotest AG receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for approval of Zutectra across the EU
08/12/2009
DGAP-News: Biotest AG:Biotest remains successful
07/07/2009
DGAP-News: Biotest AG: Further interim analyses confirm good clinical efficacy of the BT-061 monoclonal antibody.
05/15/2009
DGAP-News: Biotest AG: Successful Start into 2009
05/07/2009
DGAP-News: Biotest AG: Annual General Meeting: Shareholders Approve Dividend of EUR 0,30 per Ordinary Share and EUR 0,36 per Preference Share
04/07/2009
DGAP-News: Biotest AG: Expansion of product offering and capacity
03/11/2009
DGAP-News: Biotest AG: Successful Financial Year 2008
02/11/2009
DGAP-News: Biotest AG: Biotest acquires further plasmapheresis centre
01/21/2009
DGAP-News: Biotest AG: Cooperation secures additional plasma protein capacity
01/12/2009
DGAP-News: Biotest AG: Expansion of plasma protein product range
12/15/2008
DGAP-News: Biotest AG: Enhanced property rights for BT-062
12/10/2008
DGAP-News: Biotest AG: Biotest expands plasma recovery capacities
12/10/2008
DGAP-News: Biotest AG: European approval for Haemonine®
10/17/2008
DGAP-News: Biotest AG: Biotest: proceeding successfully
09/22/2008
DGAP-News: Biotest AG: Biotest: Promising start of clinical trial with BT062
09/08/2008
DGAP-News: Biotest AG: Biotest: monoclonal antibody BT-061 shows clear indications of efficacy in the treatment of Psoriasis
08/18/2008
DGAP-News: Biotest AG: Biotest: US approval increases potential of diagnostic business
08/07/2008
DGAP-News: Biotest AG: Biotest strengthens self-sufficiency in Plasma Proteins
07/29/2008
DGAP-News: Biotest AG: Biotest awarded patent protection in the USA
05/27/2008
DGAP-News: Biotest AG: Payout of dividends increased, forecast improved
05/16/2008
DGAP-News: Biotest AG: Successful start into the Year 2008
05/05/2008
DGAP-News: Biotest AG: research into additional indications for monoclonal antibody BT-061
04/14/2008
DGAP-News: Biotest AG: European approvals expand the market potential for plasma proteins
04/07/2008
DGAP-News: Biotest AG: Biotest: Successful launch of plasma protein business in the USA
03/11/2008
DGAP-News: Biotest AG: Biotest achieves major milestones in the development of biotherapeutics
02/22/2008
DGAP-News: Biotest AG: 2007 a very successful year for Biotest
12/05/2007
DGAP-News: Biotest AG:Biotest successfully completes acquisition of Nabi Biologics assets
11/09/2007
DGAP-News: Biotest AG: Nabi shareholders approve sale of Biologics Business Unit to Biotest
11/05/2007
DGAP-News: Biotest AG: Biotest: plasmapheresis centre in Dortmund opens
09/11/2007
DGAP-News: Biotest AG:Biotest AG acquires plasma protein business unit from Nabi Biopharmaceuticals Corp.
08/10/2007
DGAP-News: Biotest AG: Biotest remains on course for growth
08/01/2007
DGAP-News: Biotest AG:Biotest and Abbott cooperate on a clinical trial for the expansion of the indication of Cytotect®
07/16/2007
DGAP-News: Biotest AG: New clinical results increase market potential of Cytotect®
06/25/2007
DGAP-News: Biotest AG: Biotest achieves further milestones in its monoclonal antibody development
06/15/2007
DGAP-News: Biotest receives go-ahead to export culture media to the USA
05/03/2007
DGAP-News: Biotest AG: successful start to 2007
03/13/2007
DGAP-News: Biotest AG: Board of Management and Supervisory Board propose 82% dividend increase
02/14/2007
DGAP-News: Biotest AG: 2006 financial year considerably better than expected
01/04/2007
DGAP-News: Biotest AG: Orphan drug status for Cytotect® in the USA
12/21/2006
DGAP-News: Biotest AG: Major milestones achieved in the development of monoclonal antibodies. – Commencement of clinical development of BT-061.
11/14/2006
DGAP-News: Biotest AG: Biotest confirms sales and earnings target following good third quarter
11/02/2006
DGAP-News: Biotest AG:Biotest obtained approval for improved Hepatect® product in six European countries
10/20/2006
DGAP-News: Biotest AG: New Automated Assays for TANGO® Automated Blood Bank Systems under Food and Drug Administration Review
10/20/2006
DGAP-News: Biotest AG: Biotest Diagnostics Corporation Announces Appointment of Vice President, Transfusion Diagnostics
10/20/2006
DGAP-News: Biotest AG: Biotest announces important Milestone for Full Line of Manual Blood Bank Reagents
10/20/2006
DGAP-News: Biotest AG: Olympus and Biotest redefine distribution relationship for Tango® systems
09/28/2006
DGAP-News: Biotest AG: EMEA Committee in favour of Orphan Drug status for Cytotect®
08/14/2006
DGAP-News: Biotest AG: Continuing growth
07/11/2006
DGAP-News: Biotest secures exclusive rights to ImmunoGen’s world leading cytotoxic agent technologyest AG:
05/11/2006
DGAP-News: Biotest AG: Stock option programme fails to achieve required majority
05/11/2006
DGAP-News: Biotest AG:Good start to 2006 – a year of growth: Group sales up by 21%, overproportional growth recorded in earnings
03/22/2006
DGAP-News: Biotest AG:“Focused research, global growth”: Biotest increases its market share worldwide and announces ambitious targets for 2006
03/22/2006
DGAP-News: Biotest AG:Supervisory Board announces early extension of Dr. Michael Ramroth’s (CFO), contract by five years
02/17/2006
DGAP-News: Biotest AG: Successful financial year 2005: Biotest increases sales, doubles the result and reduces financial liabilities
11/14/2005
Press release: Biotest continues excellent business growth in third quarter: Revenue +9%, EBIT +43%
10/31/2005
Press release: Successful capital increase for Biotest
10/18/2005
Press release: Biotest: World’s Largest Trade Conference is Kickoff for TANGO Marketing in the U.S.
10/13/2005
Press release: Biotest: Intratect
®
approved for nine European countries
10/11/2005
Press release: Biotest AG: Capital increase - Up to EUR 30 million for research and internationalisation
09/29/2005
Press release: Biotest: New study doubles the market potential of Cytotect
®
08/05/2005
Press release: Biotest enjoys continued successful business growth - EBIT +27% in first six months 2005
07/28/2005
Press release: Biotest receives approval for TANGO reagents in US
07/01/2005
Press release: Capital increase: 10 million euro in new funds for antibody research
06/29/2005
Press release: Biotest wins TANGO tender
06/28/2005
Press release: Biotest AG and Boehringer Ingelheim Enter Into
05/20/2005
Press release: Biotest AG: Dr. Thorlef Spickschen new Chairman of the Supervisory Board
05/10/2005
Press release: Biotest : Q1 2005 continues positive trend
04/19/2005
Press release: Biotest : Successful fiscal year 2004 and first quarter of 2005
02/17/2005
Press release: Biotest AG and Lonza Enter into Manufacturing Agreement
01/26/2005
Press release: Biotest recorded revenues of EUR 218 million in 2004
01/21/2005
Press release: Biotest AG and AERES Biomedical Successfully Complete Engineering of the Antibody BT-062
11/22/2004
Press release: Biotest increases operating result by 70%
09/30/2004
Press release: STRATEC and BIOTEST conclude agreement on further development of TANGO
09/29/2004
Press release: Biotest launches new antibody product
07/08/2004
Press release: 2004 General Shareholders' Meeting – Biotest shareholders approve extensive capital measures
04/02/2004
Press release: Biotest generates operating profit in 2003
03/10/2004
Press release: Biotest sells its shareholding in SIFIN
02/23/2004
Press release: Biotest and Iranian Darou Pakhsh form joint venture
02/03/2004
Press release: Management changes at Biotest
01/26/2004
Press release: Biotest generates € 222 million turnover in 2003
10/01/2003
Press release: New chairman for the Biotest supervisory board
07/10/2003
Press release: Prof. Schulz appointed as Biotest`s new Chairman
07/01/2003
Press release: Biotest's new preparation against viral infections approved
06/16/2003
Press release: Successful Treatment of SARS Patients with Biotest Drug
06/10/2003
Press release: Biotest sells its shareholding in Envitec
03/05/2003
Press release: Biotest AG continues to market medical products
02/19/2003
Press release: New French transfusion guidelines will drive growth for Biotest's blood grouping analyser
01/29/2003
Press release: Biotest approved for Prime Standard segment
07/09/2002
Press release: Cooperation of Biotest and Olympus in the US and Canadian Market
05/22/2002
Press release: Biotest considers repurchase of shares
04/15/2002
Press release: Biotest AG achieved a 5.6 % growth in sales in 2001 and maintains dividend continuity
02/19/2002
Press release: Biotest announces stock option program
02/12/2002
Press release: Biotest Executive Dr. Reiner retired
01/21/2002
Press release: Biotest fulfills sales target